Type / Class
Equity / Ordinary Shares, par value NIS 0.01 per share
Shares outstanding
1,148,777,709
Total 13F shares
607,728,519
Share change
+38,578,733
Total reported value
$9,874,096,775
Put/Call ratio
19%
Price per share
$16.25
Number of holders
528
Value change
+$630,049,704
Number of buys
271
Number of sells
176

Quarterly Holders Quick Answers

What is CUSIP 881624209?
CUSIP 881624209 identifies TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock Finance, Inc.
13F
Company
3.8%
43,704,401
$616,669,092 31 Mar 2024
13F
Ion Asset Management Ltd.
13F
Company
3.4%
38,578,487
$544,342,451 31 Mar 2024
13F
Phoenix Financial Ltd.
13F
Company
3%
34,581,787
$488,081,116 31 Mar 2024
13F
Migdal Insurance & Financial Holdings Ltd.
13F
Company
2.6%
29,857,800
$421,294,000 31 Mar 2024
13F
Clal Insurance Enterprises Holdings Ltd
13F
Company
2.5%
28,794,366
$406,063,000 31 Mar 2024
13F
MENORA MIVTACHIM HOLDINGS LTD.
13F
Company
2.4%
28,128,744
$396,896,578 31 Mar 2024
13F
Slate Path Capital LP
13F
Company
2.3%
26,896,184
$379,505,156 31 Mar 2024
13F
Lingotto Investment Management LLP
13F
Company
2.3%
26,424,535
$372,850,189 31 Mar 2024
13F
FMR LLC
13F
Company
1.8%
21,248,407
$299,815,028 31 Mar 2024
13F
Rubric Capital Management LP
13F
Company
1.5%
17,669,588
$249,317,887 31 Mar 2024
13F
STATE STREET CORP
13F
Company
1.4%
16,223,272
$228,910,368 31 Mar 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.94%
10,748,785
$151,665,356 31 Mar 2024
13F
AustralianSuper Pty Ltd
13F
Company
0.88%
10,112,070
$140,658,894 31 Mar 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.71%
8,102,722
$113,897,125 31 Mar 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.67%
7,697,163
$108,607,000 31 Mar 2024
13F
GLENVIEW CAPITAL MANAGEMENT, LLC
13F
Company
0.65%
7,501,284
$105,843,117 31 Mar 2024
13F
SOUND SHORE MANAGEMENT INC /CT/
13F
Company
0.65%
7,494,690
$105,750,076 31 Mar 2024
13F
Alyeska Investment Group, L.P.
13F
Company
0.55%
6,345,808
$89,539,351 31 Mar 2024
13F
Eversept Partners, LP
13F
Company
0.52%
6,025,169
$85,015,135 31 Mar 2024
13F
MORGAN STANLEY
13F
Company
0.47%
5,425,620
$76,555,513 31 Mar 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.44%
5,110,126
$72,103,878 31 Mar 2024
13F
PointState Capital LP
13F
Company
0.44%
5,104,969
$72,031,113 31 Mar 2024
13F
Parsifal Capital Management, LP
13F
Company
0.44%
5,048,300
$71,231,513 31 Mar 2024
13F
Holocene Advisors, LP
13F
Company
0.43%
4,962,456
$70,020,254 31 Mar 2024
13F
Maple Rock Capital Partners Inc.
13F
Company
0.38%
4,363,401
$61,567,588 31 Mar 2024
13F
MARSHALL WACE, LLP
13F
Company
0.37%
4,215,216
$59,476,698 31 Mar 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.36%
4,161,857
$58,723,801 31 Mar 2024
13F
Neuberger Berman Group LLC
13F
Company
0.35%
4,029,716
$56,859,293 31 Mar 2024
13F
TRUIST FINANCIAL CORP
13F
Company
0.32%
3,630,768
$51,230,132 31 Mar 2024
13F
CITIGROUP INC
13F
Company
0.31%
3,617,747
$51,046,409 31 Mar 2024
13F
Legal & General Group Plc
13F
Company
0.31%
3,572,529
$50,408,385 31 Mar 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.31%
3,543,860
$50,003,871 31 Mar 2024
13F
NORTHERN TRUST CORP
13F
Company
0.31%
3,537,284
$49,911,078 31 Mar 2024
13F
Soleus Capital Management, L.P.
13F
Company
0.3%
3,486,440
$49,193,668 31 Mar 2024
13F
Swiss National Bank
13F
Company
0.29%
3,344,800
$47,195,128 31 Mar 2024
13F
Capital International Investors
13F
Company
0.28%
3,185,719
$44,950,495 31 Mar 2024
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
0.27%
3,121,998
$44,051,392 31 Mar 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.26%
3,007,618
$42,437,489 31 Mar 2024
13F
Iron Triangle Partners LP
13F
Company
0.24%
2,769,864
$39,082,781 31 Mar 2024
13F
MANGROVE PARTNERS IM, LLC
13F
Company
0.24%
2,762,154
$38,973,993 31 Mar 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.23%
2,636,066
$37,194,891 31 Mar 2024
13F
Grantham, Mayo, Van Otterloo & Co. LLC
13F
Company
0.21%
2,433,267
$34,333,397 31 Mar 2024
13F
FIL Ltd
13F
Company
0.21%
2,396,583
$33,815,786 31 Mar 2024
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.19%
2,223,464
$31,373,077 31 Mar 2024
13F
Tri Locum Partners LP
13F
Company
0.19%
2,216,188
$31,270,413 31 Mar 2024
13F
UBS Group AG
13F
Company
0.19%
2,198,202
$31,016,631 31 Mar 2024
13F
Sumitomo Mitsui Trust Group, Inc.
13F
Company
0.19%
2,159,333
$30,468,189 31 Mar 2024
13F
DEUTSCHE BANK AG\
13F
Company
0.19%
2,142,332
$30,228,305 31 Mar 2024
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.18%
2,072,506
$29,243,060 31 Mar 2024
13F
GOLDENTREE ASSET MANAGEMENT LP
13F
Company
0.18%
2,058,650
$29,047,552 31 Mar 2024
13F

Institutional Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) as of Q2 2024

As of 30 Jun 2024, TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.01 per share (TEVA) was held by 528 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 607,728,519 shares. The largest 10 holders included BlackRock Inc., FMR LLC, Ion Asset Management Ltd., Clal Insurance Enterprises Holdings Ltd, Migdal Insurance & Financial Holdings Ltd., MENORA MIVTACHIM HOLDINGS LTD., Lingotto Investment Management LLP, Phoenix Holdings Ltd., Slate Path Capital LP, and STATE STREET CORP. This page lists 531 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
474
Q2 2024 holders
528
Holder diff
54
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .